Mark Hahn

Overview

Mark Hahn received an average of $10M in total compensation, including $316K in salary, at Verona Pharma plc between 2020 and 2021. Mark Hahn also received an average of $1M at Cempra from 2012 to 2017.

Related executives

We found 14 more executives who work or worked at Verona Pharma plc and Cempra.

David Zaccardelli

Verona Pharma plc

Chief Executive Officer

Mark Hahn

Verona Pharma plc

Chief Financial Officer

Kathleen Rickard

Verona Pharma plc

Chief Medical Officer

Jan-Anders Karlsson

Verona Pharma plc

Chief Executive Officer

Daniel Wechsler

Cempra

Chief Executive Officer

Sue Cammarata

Cempra

Chief Medical Officer

John Johnson

Cempra

Chief Executive Officer

Erin Duffy

Cempra

Chief Scientific Officer

News

You may also like